Altaire Pharmaceuticals Inc.

Form 483FOIA Uncovered

Aquebogue, New YorkFEI 1000119582Issued April 19, 2019

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1000119582.

ObservationsNot available

Issue DateApril 19, 2019

Status1 Related Warning Letter

Related Inspections10

Establishment Details

Firm: Altaire Pharmaceuticals Inc.
Location: Aquebogue, New York
FEI Number: 1000119582
Product Type: Drugs
Issue Date: April 19, 2019
Country: United States

Inspection History, 2012 to 2026

NAI1

VAI6

OAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Altaire Pharmaceuticals Inc. FDA Form 483, Aquebogue, New York, April 19, 2019